🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

2,249 notícias encontradas para "first"
Foto: Ahmed ؜ / Pexels
Ultra-processed foods linked to higher levels of 'bad' fatty acids in blood, study suggest
Consumption of ultra-processed food (UPF) results in a distinct metabolic "signature" in the blood, associated with potentially adverse health conditions, suggests a new study by an international team of researchers. The paper, published in Critical Reviews in Food Science and Nu
FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Babies' brains respond to music by three months of age—while moving to it begins by their
A study suggests babies' brains recognize music from as young as 3 months of age, while spontaneous movements to music emerge by their first birthday and their ability to match movements to it develops later.
First AI agent and risk prediction model for precision diabetes management
First AI agent and risk prediction model for precision diabetes management
A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian populations, together with a related disease risk prediction model. Leveraging artifici
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-appro
First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders
First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The s
Young women diagnosed with breast cancer within three years of childbirth may face more ag
Young women diagnosed with breast cancer within three years of childbirth may face more ag
Breast cancers diagnosed during the first three years after childbirth, particularly within the first year, may be biologically more aggressive than similar cancers in women who have never given birth, according to a new study led by investigators at the UCLA Health Jonsson Compr
AI-guided CRISPR uncovers oxytocin receptor as unexpected psoriasis drug target
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis. They found an unlikely candidate: the receptor for oxytocin, a hormone
Foto: cottonbro studio / Pexels
Sleep problems in dementia care are linked more to emotional well-being than fear of falli
While fear of falling has long been linked to poor sleep among older adults, new research from George Mason University suggests that emotional well-being may be an even stronger predictor of sleep quality for people with dementia and the spouses who care for them. In what is beli
Does a person's neighborhood impact their risk of pancreatic cancer?
Does a person's neighborhood impact their risk of pancreatic cancer?
A new Yale-led study published in JNCI Cancer Spectrum is the first to examine the overall relationship between pancreatic cancer and neighborhood-level socioeconomic factors.
Eight-patient Parkinson's stem cell clinical trial confirms feasibility
A landmark study led by Lund, Sweden, has shown that transplanting stem cell-derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during t
Foto: Negative Space / Pexels
Data highlight progress toward personalized stem cell therapy for Parkinson's disease
Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jea